This material may not be published, broadcast, rewritten, or redistributed. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset . Powered and implemented by FactSet Digital Solutions . Mutual Fund and ETF data provided by Refinitiv Lipper .

Fox News senior medical analyst Dr. Marc Siegel joins'Fox News Live' to discuss the peanut allergy study and his new book, 'The Miracles Among Us.' NEW You can now listen to Fox News articles! Early peanut introduction could help to curb allergies in kids, new research suggests. Exposing children to peanuts when they are 4 to 11 months old -- instead of waiting until they are 3, as previously recommended by the American Academy of Pediatrics -- appears to be making a dent in the number of peanut allergy diagnoses, the study published in Pediatrics suggests. New onset peanut allergy dropped by 43% in kids under 3, Dr. David Hill, M.D., Ph.D., from the Division of Allergy and Immunology at the Children's Hospital of Philadelphia, told Fox News Digital.

A professor says AI chatbot software, such as ChatGPT, could restructure postsecondary education by replacing some textbooks and promoting critical thinking. As artificial intelligence has made its way into everything from content creation to health care, could "robo recipes" be next on the menu? Researchers from the Poznań University of Economics and Business in Poland entered prompts into ChatGPT -- the AI-powered large language model (LLM) developed by OpenAI -- to get meal recommendations for specific food allergies. "ChatGPT -- at least in the version that was tested in January 2023 -- generally produced balanced diet plans for people with food allergies, but not all of them were safe," Paweł Niszczota, lead researcher of the study, which was published in the journal Nutrition, told Fox News Digital. Each year, some 30,000 people visit the emergency room with food allergy reactions and 150 to 200 die from them, studies have shown.

Oral Food Challenges (OFCs) are essential to accurately diagnosing food allergy due to the limitations of existing clinical testing. However, some patients are hesitant to undergo OFCs, while those willing suffer from limited access to allergists in rural/community healthcare settings. Despite its success in predicting patient outcomes in other clinical settings, few applications of machine learning to food allergy have been developed. Thus, in this study, we seek to leverage machine learning methodologies for OFC outcome prediction. Retrospective data was gathered from 1,112 patients who collectively underwent a total of 1,284 OFCs, and consisted of clinical factors including serum-specific Immunoglobulin E (IgE), total IgE, skin prick tests (SPTs), comorbidities, sex, and age. Using these features, multiple machine learning models were constructed to predict OFC outcomes for three common allergens: peanut, egg, and milk. The best performing model for each allergen was an ensemble of random forest (egg) or Learning Using Concave and Convex Kernels (LUCCK) (peanut, milk) models, which achieved an Area under the Curve (AUC) of 0.91, 0.96, and 0.94, in predicting OFC outcomes for peanut, egg, and milk, respectively. Moreover, all such models had sensitivity and specificity values 89%. Model interpretation via SHapley Additive exPlanations (SHAP) indicates that specific IgE, along with wheal and flare values from SPTs, are highly predictive of OFC outcomes. The results of this analysis suggest that ensemble learning has the potential to predict OFC outcomes and reveal relevant clinical factors for further study.

IBM today announced a new tool that taps AI to predict when allergy symptoms are likely to flare up. It's called Allergy Insights with Watson, and it's available in The Weather Channel app for iOS and Android ahead of a launch on the web. In addition to a 15-day forecast that predicts allergy symptom risk (e.g., high, moderate, low) and a 3-day outlook for allergens, Allergy Insights delivers notifications when allergy risk is changing and explanations about how weather conditions can trigger symptoms. It also provides pollen levels by allergen (with mold coming soon), tips for managing allergies or reducing exposure, and news articles and editorial content related to allergies. According to a recent survey conducted by IBM, most allergy sufferers -- 60% -- use weather forecasts to help manage and mitigate the worst of their symptoms. But pollen metrics like tree, grass, and ragweed levels, which the bulk of apps use to assess risk, aren't necessarily good predictors, and their sources tend to be spotty.

Artificial intelligence stocks are rarer than you might think. Many companies tout AI technology initiatives and machine learning.

Drugmaker Mylan has started selling a generic version of its emergency allergy treatment EpiPen at half the price of the branded option, the cost of which drew national scorn and attracted congressional inquiries. The launch of Mylan's long-promised generic alternative is expected to still generate millions of dollars in revenue for the drugmaker while also protecting its market share against current and future competition. Mylan NV said Friday that it will charge $300 for the generic version of its lifesaving injections, which come in a two-pack. The generic version will reach retail pharmacies starting next week. The list price of an EpiPen two-pack, which is stocked by schools and parents of children with severe allergies, has grown to $608, an increase of more than 500% since 2007.